Eldred Kary's Form 4/A amendment
AmendedGalectin Therapeutics Inc (GALT) · filed Jul 23, 2024
- Accession no.
- 0001133416-24-000048
- Filed
- Jul 23, 2024
- Trade date
- Jul 22, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 23, 2024
This filing lists 1 non-derivative transaction. Open-market purchases total $956. It was filed 1 day after the trade.
This amendment replaces 0001133416-24-000046 (filed Jul 23, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eldred KaryCIK 0001543425 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2024 | Common Stock | PPurchaseAcquired | +400 | $2.39 | +$956 | 49,713 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose.
- F2
These shares are held in a special needs trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.